PeerVoice Oncology & Haematology Audio-logo

PeerVoice Oncology & Haematology Audio

Education Podcasts

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Location:

United States

Description:

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Language:

English


Episodes

"Complementing Evidence With Expert Experience: Challenging Cases in Paroxysmal Nocturnal Haemoglobinuria "

2/26/2021
"Complementing Evidence With Expert Experience: Challenging Cases in Paroxysmal Nocturnal Haemoglobinuria "

Duration:00:43:05

Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments

2/24/2021
Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments

Duration:00:15:08

When Physics Fuses With Medicine: A New Therapeutic Modality for mCRPC

2/22/2021
When Physics Fuses With Medicine: A New Therapeutic Modality for mCRPC

Duration:00:20:08

GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!

2/17/2021
GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!

Duration:00:19:13

Beyond HPIs for Advanced Basal Cell Carcinoma: Exploring the Clinical Implications of New Evidence

1/22/2021
Beyond HPIs for Advanced Basal Cell Carcinoma: Exploring the Clinical Implications of New Evidence

Duration:00:19:45

Cardiovascular Risk and Prostate Cancer: Clinical Perspectives on ADT

1/15/2021
Cardiovascular Risk and Prostate Cancer: Clinical Perspectives on ADT

Duration:00:22:24

Interpreting the Most Recent Clinical Data With A Real-World Lens: Implications on Hepatocellular Carcinoma Management

1/11/2021
Interpreting the Most Recent Clinical Data With A Real-World Lens: Implications on Hepatocellular Carcinoma Management

Duration:00:16:00

A Look at Emerging SMA Outcomes: Highlights of WMS 2020

1/7/2021
A Look at Emerging SMA Outcomes: Highlights of WMS 2020

Duration:00:09:11

PARPs in Practice in mCRPC: A Look at the Latest Data

12/18/2020
PARPs in Practice in mCRPC: A Look at the Latest Data

Duration:00:17:07

Going Below the Surface in Advanced Basal Cell Carcinoma: Analysing the Latest Evidence

12/7/2020
Going Below the Surface in Advanced Basal Cell Carcinoma: Analysing the Latest Evidence

Duration:00:49:55

Practice Challenges in Advanced EGFR-Mutant NSCLC: Clarifying First-Line Strategies

11/9/2020
Practice Challenges in Advanced EGFR-Mutant NSCLC: Clarifying First-Line Strategies

Duration:00:25:11

Transforming Management of Early-Stage EGFR-Mutant NSCLC: Insights From the Latest Data

11/3/2020
Transforming Management of Early-Stage EGFR-Mutant NSCLC: Insights From the Latest Data

Duration:00:18:48

Extending Overall Survival in Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) While Maintaining Quality of Life: Can We Have it All?

11/2/2020
Extending Overall Survival in Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) While Maintaining Quality of Life: Can We Have it All?

Duration:01:29:49

Practical Approaches to Optimise Management of Advanced Renal Cell Carcinoma

11/2/2020
Practical Approaches to Optimise Management of Advanced Renal Cell Carcinoma

Duration:00:21:07

Novel Therapies for Patients With DLBCL: What Does the Future Hold?

10/22/2020
Novel Therapies for Patients With DLBCL: What Does the Future Hold?

Duration:01:04:20

New Targets in Heart Failure: Congress Updates on SGLT2 Inhibitors

10/21/2020
New Targets in Heart Failure: Congress Updates on SGLT2 Inhibitors

Duration:00:12:31

A Patient-Centred Approach to Managing Prostate Cancer

9/30/2020
A Patient-Centred Approach to Managing Prostate Cancer

Duration:00:17:29

Deciphering the Role of MET Alterations in Advanced NSCLC: Unmet Needs

9/28/2020
Deciphering the Role of MET Alterations in Advanced NSCLC: Unmet Needs

Duration:00:15:43

Are All Biologics the Same? Optimal Treatment Strategies for Patients With Inflammatory Bowel Disease

9/21/2020
Are All Biologics the Same? Optimal Treatment Strategies for Patients With Inflammatory Bowel Disease

Duration:00:21:29

Hidden in Plain Sight: Uncovering Truncal Acne

9/9/2020
Hidden in Plain Sight: Uncovering Truncal Acne

Duration:00:13:02